Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing

A novel RIP-Seq assay has been developed to detect autoantibodies targeting ribonucleoprotein complexes in SSc patients. This method successfully identified RNA molecules associated with ribonucleoproteins known to be targeted by SSc-related autoantibodies, validating both the assay and the analysis strategy. Additionally, this approach uncovered RNA molecules associated with ribonucleoproteins that were not previously identified as targets of SSc patients' sera, suggesting potential new autoantibody candidates in this disease.

Authors

Institutions

Publication Details

Journal
Journal of Autoimmunity
Published
2024-11-04
DOI
https://doi.org/10.1016/j.jaut.2024.103328
Citations
2
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing

Albert Selva-O’Callaghan, Laura Viñas-Giménez, Fernando Gordillo-González, Laura Batlle-Masó et al.
2 citations
Journal of Autoimmunity
Systemic Sclerosis and Related Diseases
0.85
article

Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing

Albert Selva-O’Callaghan, Laura Viñas-Giménez, Fernando Gordillo-González, Laura Batlle-Masó, Maria Teresa Sanz-Martínez, Roger Colobrán, Ricardo Pujol‐Borrell, L. Triginer, Javier J. Martin, Neil McHugh, Eduardo Andrés‐León, Sarah Tansley, Janire Perurena-Prieto, Alfredo Castillo, Carmen Pilar Simeón‐Aznar, Claudia Codina-Clavaguera
article en
2 citations

Abstract

A novel RIP-Seq assay has been developed to detect autoantibodies targeting ribonucleoprotein complexes in SSc patients. This method successfully identified RNA molecules associated with ribonucleoproteins known to be targeted by SSc-related autoantibodies, validating both the assay and the analysis strategy. Additionally, this approach uncovered RNA molecules associated with ribonucleoproteins that were not previously identified as targets of SSc patients' sera, suggesting potential new autoantibody candidates in this disease.

Journal of AutoimmunityVol. 149
Hebron University (PS), Universitat Autònoma de Barcelona (ES), Vall d'Hebron Institut de Recerca (ES), Vall d'Hebron Hospital Universitari (ES), Instituto de Parasitología y Biomedicina "López - Neyra" (ES), University of Bath (GB)
Zero hunger
Openalex Percentile: Top 25%
Systemic Sclerosis and Related Diseases
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.